Patients With Type 2 Diabetes Have an Increased Demand for Pacemaker Treatment: A Comparison With Age- and Sex-Matched Control Subjects From the General Population.
Elina RautioFredrik GadlerSoffia GudbjörnsdottirStefan FranzénLars RydenAnn-Marie SvenssonLinda G MellbinPublished in: Diabetes care (2020)
The need for PM treatment is higher in patients with type 2 diabetes than in matched population-based control subjects. Age, diabetes duration, and HbA1c seem to be risk factors for PM treatment.